Agenus Inc AGEN

Healthcare Biotechnology

Agenus Inc. is an immuno-oncology (I-O) company targeting cancer and infectious diseases with a pipeline of immunological agents. It is specialized in developing therapies to activate the body's immune system against cancer and infections. Its pipeline includes immune-modulatory antibodies, adoptive cell therapies (via MiNK Therapeutics, Inc.), and vaccine adjuvants (via SaponiQx, Inc.). Its primary focus is I-O, and its diverse pipeline is supported by its in-house capabilities, including current good manufacturing practice (cGMP) manufacturing and a clinical operations platform. Its most advanced antibody candidates are botensilimab (a multifunctional immune cell activator and human Fc-enhanced cytotoxic T-lymphocyte antigen 4 (CTLA-4) blocking antibody (AGEN1811)) and balstilimab (a programmed death receptor-1 (PD-1) blocking antibody). Its pipeline includes several classes of immunotherapies: checkpoint inhibitors, immune activators, and tumor microenvironment conditioning agents.

NDAQ:AGEN - Post by User

Agenus Inc

<< Previous

Bullboard Posts

Next >>

Post by coolfooldumbguyon Jul 18, 2024 11:29am

42 Views

Post# 36138438

Using technical analysis for this one.

My buy order of 5000 shares was filled at $6.73 cents per share,as this biotech stock was pounded down today, and my method of using Dollar Cost Averaging,or DCA for short, will be used for more buying in the coming weeks,so glta,as we will be finding out how low this stock will go.As always you should complete your own due diligence,but it is cheap.

<< Previous

Bullboard Posts

Next >>

Unique Battery Metals opportunity in Quebec